Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-01-22

FDA Approved: FLUVOXAMINE MALEATE — Original Application (Bionpharma Inc.)

View source ↗

Summary

The FDA approved the original ANDA for fluvoxamine maleate from Bionpharma Inc. as a generic version of fluvoxamine, indicated for obsessive-compulsive disorder…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluvoxamine Maleate (Fluvoxamine maleate)

Snippet

ORIG AP for FLUVOXAMINE MALEATE (FLUVOXAMINE MALEATE)